Treatment of Influenza A in Patients with Asthma and Smoking History
Antiviral Selection
- The Centers for Disease Control and Prevention recommends oseltamivir 75 mg orally twice daily for 5 days as the treatment for patients with asthma and smoking history, as zanamivir is contraindicated in patients with underlying airways disease such as asthma 1, 2, 3
- Zanamivir is absolutely contraindicated in patients with asthma or chronic obstructive pulmonary disease due to risk of serious bronchospasm, including fatalities 1, 2, 3
- Smoking history further compounds the respiratory risk, making zanamivir even more inappropriate for this patient 2, 3
Oseltamivir Dosing and Timing
- Standard adult dosing is oseltamivir 75 mg orally twice daily for 5 days, as recommended by the Centers for Disease Control and Prevention 1, 2, 3
- Treatment should ideally be initiated within 48 hours of symptom onset for maximum benefit, though patients with high-risk conditions like asthma may benefit even when started later 4, 5
- Dose adjustment to 75 mg once daily is required if creatinine clearance is <30 mL/min, as recommended by medical guidelines 4, 5
Antibiotic Considerations
- Antibiotics are not routinely indicated for uncomplicated influenza with asthma exacerbation in the absence of bacterial pneumonia, as stated by medical guidelines 4, 5
- Consider antibiotics only if: worsening symptoms develop after initial improvement, signs of bacterial pneumonia emerge, or the patient develops purulent sputum with systemic signs of infection 4, 5
Common Pitfalls to Avoid
- Never prescribe zanamivir to patients with any underlying airways disease, regardless of severity, as recommended by the Centers for Disease Control and Prevention 1, 2, 3
- Do not withhold oseltamivir from high-risk patients (asthma, smokers) even if presenting slightly beyond 48 hours, as they may still benefit significantly 4, 5